3D Bioprinting Market
- Published Date: Aug-2021 |
- 180 Pages |
- Report ID: MD0128
3D Bioprinting Market
The 3D Bioprinting market is expected to grow from USD 0.78 billion in 2019 to USD 3.07 billion by 2026 at a CAGR of 22% from 2020 to 2026.
3D bioprinting is a medical application of 3D printers. This system involves 3D printing of biological tissues and organs through the layering of living cells. The method of 3D bioprinting mainly comprises of three stages, namely, pre-bioprinting, bioprinting, and post-bioprinting. During the method of 3D bioprinting, the cell function and viability of the output construct is preserved, which may be used for R&D in various medical areas. 3D bioprinting is especially employed for developing organ and tissue constructs, which may be used for R&D of medicine, scaffolds, and development of medical implants. The development of the market is especially driven by the technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting within the pharmaceutical and cosmetology industries, and rising public and personal funding to support bioprinting research activities. These factors have prompted market players to enhance and strengthen their current manufacturing and distribution capabilities, especially in emerging markets, which are expected to witness the very best growth. The global market is segregated on the basis of Component as 3D Bioprinters and Bionics. Based on Application the market is segmented in Research Applications, Clinical Application, and PV (Passenger Vehicle). Based on End User the market is segmented in Research Organization & Academic Institutes, Biopharmaceuticals Companies, and Hospital. Based on material, the market is segmented in Living Cells, Hydrogels, Extracellular Matrices, and Other Biomaterials.
The global market report provides geographical analysis covering regions, such as the market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Advanced Solutions Life Sciences, Allevi Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., Digilab, Inc., Envisiontec, Gesim, Nano3D Biosciences, Inc., Organovo Holdings, Inc., and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global 3D Bioprinting market has been segmented as below:
By Component
- 3D Bioprinters
- Microextrusion bioprinting
- Inkjet 3D Bioprinting
- Laser-assisted Bioprinting
- Magnetic 3D Bioprinting
- Other technologies
- Bioinks
- Natural Bioinks
- Hybrid Bioinks
- Synthetic Bioinks
By Application
- Research Applications
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
- Clinical Application
- Skin
- Bone & Cartilage
- Blood Vessels
- Other Clinical Applications
- PV (Passenger Vehicle)
By End-User
- Research Organization & Academic Institutes
- Biopharmaceuticals Companies
- Hospital
By Material
- Living Cells
- Hydrogels
- Extracellular Matrices
- Other Biomaterials
By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
By Company
- Advanced Solutions Life Sciences
- Allevi Inc.
- Aspect Biosystems Ltd.
- Cellink
- Cyfuse Biomedical K.K.
- Digilab, Inc.
- Envisiontec
- Gesim
- Nano3D Biosciences, Inc.
- Organovo Holdings, Inc.
- Poietis
- Regenhu
- Regenovo Biotechnology Co., Ltd.
- Rokit Healthcare
- Tevido Biodevices
The report covers the below scope:
- Global market sizes from 2019 to 2026, along with CAGR for 2020-2026
- Market size comparison for 2020 vs 2026, with actual data for 2020, estimates for 2021 and forecast from 2021 to 2026
- Global market trends, covering a comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
- Comprehensive company profiles of the key industry players
The years considered for the study are as follows:
- Base year - 2019
- Estimated year - 2020
- Projected year - 2021
- Forecast period - 2021 to 2025
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Advanced Solutions Life Sciences, Allevi Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., Digilab, Inc., Envisiontec, Gesim, Nano3D Biosciences, Inc., Organovo Holdings, Inc., and others.
Why to Buy this Report:
- Gain detailed insights on the 3D Bioprinting industry trends
- Find a complete analysis of the market status
- Identify the market opportunities and growth segments
- Analyze competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Target Audience:
The report targeted the existing players in the industry is as follows:
- Market Manufacturers/Service Providers
- Market Wholesale/Traders
- Investment and Financial Institutions
Free and Paid Customization based on the requirement
Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- 3D Bioprinting Market, By Component
5.1 Introduction
5.2 3D Bioprinters
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Bioinks
5.3.1 Market Overview
5.3.2 Market Size and Forecast
- 3D Bioprinting Market, By Application
6.1 Introduction
6.2 Research Applications
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Clinical Application
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 PV (Passenger Vehicle)
6.4.1 Market Overview
6.4.2 Market Size and Forecast
- 3D Bioprinting Market, By End User
7.1 Introduction
7.2 Research Organization & Academic Institutes
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Biopharmaceuticals Companies
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Hospital
7.4.1 Market Overview
7.4.2 Market Size and Forecast
- 3D Bioprinting Market, By Material
8.1 Introduction
8.2 Living Cells
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Hydrogels
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Extracellular Matrices
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Other Biomaterials
8.5.1 Market Overview
8.5.2 Market Size and Forecast
- 3D Bioprinting Market, By Geography
9.1 Introduction
9.2 Europe
9.2.1 Europe Market, By Component
9.2.2 Europe Market, By Application
9.2.3 Europe Market, By End User
9.2.4 Europe Market, By Material
9.3 North America
9.3.1 North America Market, By Component
9.3.2 North America Market, By Application
9.3.3 North America Market, By End User
9.3.4 North America Market, By Material
9.4 Asia Pacific
9.4.1 Asia Pacific Market, By Component
9.4.2 Asia Pacific Market, By Application
9.4.3 Asia Pacific Market, By End User
9.4.4 Asia Pacific Market, By Material
9.5 Rest of The World
9.5.1 Rest of The World Market, By Component
9.5.2 Rest of The World Market, By Application
9.5.3 Rest of The World Market, By End User
9.5.4 Rest of The World Market, By Material
- Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
- Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
- Advanced Solutions Life Sciences
- Allevi Inc.
- Aspect Biosystems Ltd.
- Cellink
- Cyfuse Biomedical K.K.
- Digilab, Inc.
- Envisiontec
- Gesim
- Nano3D Biosciences, Inc.
- Organovo Holdings, Inc.
- Poietis
- Regenhu
- Regenovo Biotechnology Co., Ltd.
- Rokit Healthcare
- Tevido Biodevices
The global 3D Bioprinting market has been segmented as below:
By Component
- 3D Bioprinters
- Microextrusion bioprinting
- Inkjet 3D Bioprinting
- Laser-assisted Bioprinting
- Magnetic 3D Bioprinting
- Other technologies
- Bioinks
- Natural Bioinks
- Hybrid Bioinks
- Synthetic Bioinks
By Application
- Research Applications
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
- Clinical Application
- Skin
- Bone & Cartilage
- Blood Vessels
- Other Clinical Applications
- PV (Passenger Vehicle)
By End-User
- Research Organization & Academic Institutes
- Biopharmaceuticals Companies
- Hospital
By Material
- Living Cells
- Hydrogels
- Extracellular Matrices
- Other Biomaterials
By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
By Company
- Advanced Solutions Life Sciences
- Allevi Inc.
- Aspect Biosystems Ltd.
- Cellink
- Cyfuse Biomedical K.K.
- Digilab, Inc.
- Envisiontec
- Gesim
- Nano3D Biosciences, Inc.
- Organovo Holdings, Inc.
- Poietis
- Regenhu
- Regenovo Biotechnology Co., Ltd.
- Rokit Healthcare
- Tevido Biodevices